TRIAZOLE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME

WIPO Patent Application WO/2003/042188

A1

A compound usable in treatments for fungal infectious diseases. It is a compound represented by the following formula (I) or a pharmacologically acceptable salt or solvate thereof: (I) wherein A represents substituted phenyl or a 5− to 7−membered, (un)saturated, optionally substituted heterocyclic group, provided that the substituted phenyl may have been substituted by substituted C₁₋₆ alkyl, optionally substituted sulfonyl, a 5− to 7−membered, (un)saturated, carbocyclic or heterocyclic group, etc.&semi and p is 0 or 1.

SETSU FUMIHITO (JP)
UMEMURA EIJIROU (JP)
SASAKI KAZUE (JP)
TADAUCHI KAORI (JP)
OKUTOMI TAKAFUMI (JP)
OHTSUKA KEIKO (JP)
TAKAHATA SHOU (JP)

PCT/JP2002/011960

May 22, 2003

November 15, 2002

Click for automatic bibliography generation  

MEIJI SEIKA KAISHA (JP)
SETSU FUMIHITO (JP)
UMEMURA EIJIROU (JP)
SASAKI KAZUE (JP)
TADAUCHI KAORI (JP)
OKUTOMI TAKAFUMI (JP)
OHTSUKA KEIKO (JP)
TAKAHATA SHOU (JP)

A61K31/4196; A61K31/429; A61K31/4439; A61K31/4523; A61K31/454; A61K31/4709; A61K31/4725; A61K31/506; A61K31/5377; A61P31/10; C07B61/00; C07D249/08; C07D401/10; C07D401/14; C07D403/10; C07D403/14; C07D513/04; C07D521/00; (IPC1-7): C07D249/08; A61K31/4196; A61K31/422; A61K31/4245; A61K31/429; A61K31/433; A61K31/4439; A61K31/4523; A61K31/454; A61K31/4709; A61K31/4725; A61K31/498; A61K31/506; A61K31/5377; C07D401/10; C07D401/14; C07D403/10; C07D403/12; C07D403/14; C07D413/10; C07D417/10; C07D513/04

WO1992017474A1

1992-10-15

US4503063A	1985-03-05
EP0115400A1	1984-08-08

Yoshitake, Kenji (Room 323 Fuji Bldg., 2-3, Marunouchi 3-chom, Chiyoda-ku Tokyo, JP)

View/Download PDF      PDF Help

Previous Patent: SERIN PROTEASE INHIBITORS

Next Patent: PROCESS FOR PRODUCING 1−H−1,2,4−TRIAZOLE−3−CARBOXYLIC ACID ESTER